Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

GridAI Technologies Corp.

Company price
3.45 USD 0.09 ( 2.68%)
Last update at 2026-11-19T21:00:00Z
VOLUME
81344
Market Cap
21.54M

Momentum Score

…

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.16
Low
3.64
High
52 Week Price Range
1.87
Low
6.93
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
3.36
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.10
ROE
-
Net Debt
1.36M
ROCE
-21.21%
Diluted EPS TTM
-6.47

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6.64M -15.62M -15.79M -14.63M -58.54M
Minority interest 0.16M - - - -
Net income -6.39M -18.06M -15.79M -14.63M -58.54M
Selling general administrative 5.50M 14.72M 10.74M 11.99M 18.38M
Selling and marketing expenses - 0.16M - - -
Gross profit -1.23M -0.05M -0.03M -0.11M -0.54M
Reconciled depreciation 0.57M 0.05M 0.03M 0.03M 0.54M
Ebit -7.08M -15.62M -15.77M -14.61M -58.53M
Ebitda -6.51M -15.57M -15.74M -14.58M -57.99M
Depreciation and amortization 0.57M 0.05M 0.03M 0.03M 0.54M
Operating income -7.08M -15.62M -15.77M -12.68M -59.06M
Other operating expenses 7.12M 15.62M 15.77M 12.68M 59.06M
Interest expense 0.49M - 0.02M 0.02M 0.01M
Tax provision -0.40M - - - -
Interest income - - 0.00M 0.01M 0.00M
Net interest income -0.49M 0.00M -0.02M -0.01M -0.01M
Income tax expense -0.40M 0.00M - - -
Total revenue 0.04M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 5.85M 15.62M 15.77M 12.68M 59.06M
Cost of revenue 1.27M 0.05M 0.03M 0.11M 0.54M
Total other income expense net 0.44M 0.00M -0.02M -1.95M 0.52M
Net income from continuing ops -6.24M -15.62M -15.79M -14.63M -58.54M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 48.55M 85.41M 6.88M 5.44M 11.79M
Intangible assets 21.84M - - - -
Other current assets 0.36M 83.32M 1.24M 0.00M 1.18M
Total liab 19.72M 27.61M 3.28M 2.70M 19.61M
Total stockholder equity 23.71M 57.80M 3.60M 2.74M -7.82M
Other current liab 9.51M 24.42M 1.90M 1.09M 8.87M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 3.89M 61.68M 0.00M 0.00M 0.00M
Retained earnings -208.78M -202.39M -184.33M -168.53M -153.90M
Good will 24.12M 1.68M 1.68M 1.68M 1.91M
Other assets 0.00M - - - -
Cash 0.90M 0.16M 3.71M 1.36M 8.25M
Total current liabilities 15.16M 27.55M 3.13M 2.48M 12.30M
Current deferred revenue - - - 1.08M 8.86M
Net debt 1.36M -0.02M -2.88M -0.48M -7.22M
Short term debt 2.26M 0.16M 0.68M 0.67M 0.72M
Short long term debt 2.03M - 0.61M 0.60M 0.64M
Short long term debt total 2.26M 0.14M 0.83M 0.88M 1.03M
Other stockholder equity 228.56M 198.51M 187.93M 171.28M 147.31M
Total current assets 2.60M 83.48M 4.96M 3.41M 9.42M
Net receivables 1.34M - - 0.09M -
Inventory - - - 1.95M -
Accounts payable 3.38M 2.96M 0.55M 0.72M 2.71M
Accumulated other comprehensive income 0.04M - 0.00M - -1.22M
Non currrent assets other 0.90M 0.10M 0.01M 0.04M 0.04M
Non current assets total 45.96M 1.93M 1.93M 2.03M 2.37M
Capital lease obligations 0.24M 0.14M 0.21M 0.28M 0.39M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities 0.32M 0.09M -0.50M - -10.32M
Net borrowings 3.00M -0.64M -0.60M -0.64M 0.09M
Total cash from financing activities 5.89M 5.58M 15.23M 15.74M 44.76M
Net income -6.55M -18.06M -15.79M -14.63M -58.54M
Change in cash 0.71M -3.55M 2.35M -6.86M 2.19M
Begin period cash flow 0.18M 3.73M 1.38M 8.25M 6.06M
End period cash flow 0.90M 0.18M 3.73M 1.38M 8.25M
Total cash from operating activities -5.70M -9.22M -12.38M -22.34M -32.29M
Issuance of capital stock 3.47M 6.23M 15.83M 23.25M 39.77M
Depreciation 0.57M 0.05M 0.03M 0.03M 0.54M
Other cashflows from investing activities 9.04M - - - -0.01M
Dividends paid 0.34M 0.24M - - -
Change to account receivables -1.62M - 0.09M -0.09M 0.55M
Other cashflows from financing activities -0.75M 0.24M 0.00M -6.67M 12.01M
Capital expenditures 0.00M 0.00M 0.50M 0.00M 10.32M
Change in working capital -0.34M 2.53M 2.19M -10.50M 17.10M
Stock based compensation 0.73M 0.63M 1.04M 0.77M 1.37M
Other non cash items -0.11M 5.63M 0.16M 1.99M 7.24M
Free cash flow -5.70M -9.22M -12.88M -22.34M -42.61M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GRDX
GridAI Technologies Corp.
0.09
2.68%
3.45 - - 38.83 2.06 157.46 -0.10
NVO
Novo Nordisk A/S
-0.54
1.36%
38.90 41.58 31.15 2.13 32.99 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc
-
-%
520.66 30.22 24.27 10.36 6.50 9.99 24.66
REGN
Regeneron Pharmaceuticals Inc
2.34
0.25%
923.34 29.07 20.12 7.57 3.82 6.95 19.42
ARGNF
argenx SE
-
-%
965.00 45.77 31.25 13.84 7.12 11.38 36.06

Profile*

GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

91 George St, Edinburgh, United Kingdom, EH2 3ESL

Name Title Year Born
Mr. Jason David Sawyer CEO & Director 1972
Ms. Anna Skowron Interim Chief Financial Officer 1988
Mr. Marshall Chapin Chief Executive Officer of GridAI, Inc NA
Ms. Anna Skowron Interim Chief Financial Officer 1987

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…